文献速递冠心病外科瓣膜外科

远程缺血预处理在单纯主动脉瓣与冠状动脉搭桥手术中的随机试验

Remote ischaemic preconditioning in isolated aortic valve and coronary artery bypass surgery: a randomized trial†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该多中心随机对照试验纳入124例患者,其中64例接受冠状动脉旁路移植术(CABG),60例接受主动脉瓣置换术,随机分为假处理组或远程缺血预处理组。结果显示,远程缺血预处理未改变CABG和主动脉瓣置换两组患者的肌钙蛋白I释放程度、炎症标志物水平及心脏能量代谢。结论认为,远程缺血预处理在单纯CABG或主动脉瓣手术患者中未提供额外的心脏保护作用。

要点

  • 远程缺血预处理未减少CABG或主动脉瓣手术后的肌钙蛋白I释放。
  • 远程缺血预处理未改变炎症标志物(IL-6、IL-8、IL-10、TNF-α)水平。
  • 远程缺血预处理未影响左右心室能量代谢物的保存。

核心结论

  • 远程缺血预处理在单纯CABG或主动脉瓣手术患者中未提供额外心脏保护作用。

研究设计与样本

  • 两中心随机对照试验,2013年2月至2015年4月共招募124例患者,其中CABG 64例,主动脉瓣置换60例,随机分为假处理组或预处理组。

主要发现

  • 远程缺血预处理未改变CABG和主动脉瓣置换两组患者的肌钙蛋白I释放程度。
  • 远程缺血预处理未改变CABG和主动脉瓣置换两组患者的炎症标志物水平。
  • 远程缺血预处理未改变CABG和主动脉瓣置换两组患者的心脏能量代谢。

临床怎么用

  • 对于单纯CABG或主动脉瓣手术患者,不应以心脏保护为目的常规应用远程缺血预处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This trial was designed and patients were recruited at a time when the benefits of remote ischaemic preconditioning during open-heart surgery were still controversial. We focused on a homogeneous patient population undergoing either isolated aortic valve replacement or coronary artery bypass grafting (CABG) surgery by investigating cardiac injury, metabolic stress and inflammatory response. METHODS: A 2-centre randomized controlled trial recruited a total of 124 patients between February 2013 and April 2015. Of them, 64 patients underwent CABG and 60 patients underwent aortic valve replacement. Patients were randomized to either sham or preconditioning. Remote ischaemic preconditioning was applied following anaesthesia and before sternotomy. Myocardial injury and inflammatory response were assessed by serially measuring cardiac troponin I, and interleukin-6, 8, 10 and the tumour necrosis factor (TNF-α). Biopsies from the left and the right ventricles were harvested after ischaemic reperfusion injury for nucleotides analysis. RESULTS: Application of remote ischaemic preconditioning did not alter the degree of troponin I release, levels of inflammatory markers and cardiac energetics in both the CABG and the aortic valve replacement groups. CONCLUSIONS: Preconditioning did not confer any additional cardioprotection in terms of reducing the levels of troponin I and inflammatory markers and preserving left and right ventricle energy metabolites in patients undergoing isolated CABG or aortic valve surgery. CLINICAL TRIAL REGISTRATION NUMBER: International Standard Randomized Controlled Trial Number (ISRCTN) registry ID 33084113 (doi: 10.1186/ISRCTN33084113) and UK controlled randomized trial number (UKCRN) registry ID 13672.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Moscarelli M, Fiorentino F, Suleiman MS, et al. Remote ischaemic preconditioning in isolated aortic valve and coronary artery bypass surgery: a randomized trial†. Eur J Cardiothorac Surg. 2019. PMID: 30544237. doi:10.1093/ejcts/ezy404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。